Week 8 Final Exam: NR546 NR-546

Week 8 Final Exam: NR546 / NR-546

(Latest Update 2025 / 2026) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | Review Questions and Answers | 100% Correct | Grade A - Chamberlain

Question:

AD meds: Lifespan Considerations

Answer:

Cholinesterase inhibitors are not recommended in pregnancy and lactation

Question:

AD: Treating Psychiatric and Behavioral Symptoms

Answer:

first-line pharmacologic treatment of aggression and agitation in dementia is SSRI/SNRI therapy.

• / 3

-often treated with antipsychotic medication binding at the receptor site.• not FDA approved for dementia treatment due to risks for mortality and cardiovascular side effects

Question:

If an AD medication is discontinued:

Answer:

the medication may not be as effective if restarted

Question:

Current gold standard of treatment for cognitive symptoms includes

Answer:

pharmacologic management with a cholinesterase inhibitor (ChEIs) and an N-methyl-Daspartate (NMDA) receptor antagonist.

Question:

Four major causes of Dementia

Answer:

-Alzheimer Disease (AD) -vascular dementia -Lewy body dementias (LBD) 2 / 3

-frontotemporal dementia (FTD)

Question:

Hallmarks of ad seen in the brain at autopsy are

Answer:

(1) amyloid-beta (Aβ), aggregated into plaques

(2) neurofibrillary tangles composed of hyperphosphorylated tau protein

(3) substantial neuronal cell loss

Question:

Differential diagnosis, clinical presentation: Vascular dementia

Answer:

-Impaired abstraction, mental flexibility, processing speed, and working memory -Verbal memory is better preserved

-Slower cognitive decline

-Dementia occurs within several months of a stroke

• / 3